Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapyOA
Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy
Hira Khan;Khushbakhat Alia;Yusra Al Dhaheri;Muhammad Naseem;Rabah Iratni;Edgar Serfling;Khalid Muhammad
Department of Biology,College of Science,United Arab Emirates University,Al Ain,UAEDepartment of Biology,College of Science,United Arab Emirates University,Al Ain,UAEDepartment of Biology,College of Science,United Arab Emirates University,Al Ain,UAEDepartment of Environmental Science and Sustainability,College of Natural and Health Sciences,Zayed University,Abu Dhabi,UAE||Department of Bioinformatics,Biozentrum Am Hubland,University of Würzburg,Würzburg,GermanyDepartment of Biology,College of Science,United Arab Emirates University,Al Ain,UAEDepartment of Pathology,University of Würzburg,Würzburg,GermanyDepartment of Biology,College of Science,United Arab Emirates University,Al Ain,UAE||Zayed Bin Sultan Al Nahyan Center for Health Sciences,United Arab Emirates University,Al Ain,UAE
cancer progressionimmune evasionnuclear factor of activated T cells(NFAT)precision cancer therapytumor microenvironment(TME)
cancer progressionimmune evasionnuclear factor of activated T cells(NFAT)precision cancer therapytumor microenvironment(TME)
《动物模型与实验医学（英文）》 2026 (7)
1338-1352,15
UAE University,Grant/Award Number:G-4960,G-5310 and G-5500
评论